Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-874
Closed -$66.1K 3846
2026
Q1
$66.1K Buy
874
+172
+25% +$12.9K ﹤0.01% 1199
2025
Q4
$52.3K Buy
702
+200
+40% +$14.6K ﹤0.01% 1207
2025
Q3
$33.9K Sell
502
-14
-3% -$929 ﹤0.01% 1348
2025
Q2
$33.6K Sell
516
-218
-30% -$13.1K ﹤0.01% 1244
2025
Q1
$45.3K Buy
734
+722
+6,017% +$47.8K ﹤0.01% 1067
2024
Q4
$865 Sell
12
-19
-61% -$1.48K ﹤0.01% 2069
2024
Q3
$2.52K Buy
31
+25
+417% +$2K ﹤0.01% 1815
2024
Q2
$446 Buy
6
+2
+50% +$150 ﹤0.01% 1869
2024
Q1
$312 Hold
4
﹤0.01% 1603
2023
Q4
$286 Hold
4
﹤0.01% 1627
2023
Q3
$278 Buy
+4
New +$302 ﹤0.01% 1615

Other funds holding HOLX

Larson Financial Group's HOLX Position: Q2 2026 in Review

Larson Financial Group sold out of Hologic (HOLX) in Q2 2026, closing a stake of 874 shares — an estimated $66.1K sold.

Larson Financial Group first reported a position in HOLX in Q3 2023 and held it in 11 quarters. The position peaked at $66.1K in Q1 2026. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.

  • Larson Financial Group reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
  • Larson Financial Group sold 874 Hologic shares in Q2 2026, an estimated $66.1K.
  • Larson Financial Group first reported a position in Hologic in Q3 2023 and held it in 11 quarters.
  • Larson Financial Group's Hologic position peaked at $66.1K in Q1 2026.
  • 3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.

Based on Larson Financial Group's 13F filing for Q2 2026, filed 14 Aug 2026.